HEMISPHERX BIOPHARMA, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 11244
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0199,449 METHOD OF REDUCING ANTIGENIC DRIFT OR REASSORTMENT OF VIRUSES IN A HOST ANIMAL USING ALPHA INTERFERONAug 21, 14Jul 14, 16[A61K, C12Q]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9315538 Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activityFeb 10, 14Apr 19, 16[C07H, A61K, C12N]
8722874 Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activityMar 31, 11May 13, 14[C07H]
8075877 Broad spectrum immune and antiviral gene modulation by oral interferonMar 02, 07Dec 13, 11[A61K]
8075878 Broad spectrum immune and antiviral gene modulation by oral interferonJun 18, 07Dec 13, 11[A61K]
7943147 dsRNAs as influenza virus vaccine adjuvants or immuno-stimulantsDec 06, 06May 17, 11[A61K]
7678774 Treating severe acute respiratory syndromeJan 26, 07Mar 16, 10[A61K]
6130206 Treating viral infections associated with chronic fatigue with dsRNAJan 23, 95Oct 10, 00[A61K, C12N]
5763417 Protection from septic shock subsequent to injury by dsRNAsJun 06, 95Jun 09, 98[A61K]
5683986 Elaboration of host defense mediators into biological fluids by systemic dsRNA treatmentFeb 03, 95Nov 04, 97[A61K, C07H]
5593973 Treatment of viral hepatitis with mismatched dsRNAOct 05, 94Jan 14, 97[A61K, C12Q]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0335,112 NOVEL DOUBLE-STRANDED RIBONUCLEIC ACIDS WITH RUGGED PHYSICO-CHEMICAL STRUCTURE AND HIGHLY SPECIFIC BIOLOGIC ACTIVITYAbandonedMay 12, 14Nov 13, 14[A61K, C12N]
2014/0170,191 NOVEL DOUBLE-STRANDED RIBONUCLEIC ACIDS WITH RUGGED PHYSICO-CHEMICAL STRUCTURE AND HIGHLY SPECIFIC BIOLOGIC ACTIVITYAbandonedFeb 04, 13Jun 19, 14[C12N]
2011/0223,198 dsRNAs as influenza virus vaccine adjuvants or immuno-stimulantsAbandonedApr 19, 11Sep 15, 11[A61K, A61P]
2010/0160,413 Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activityAbandonedNov 13, 09Jun 24, 10[C07H, A61K]
2010/0104,533 EARLY INTERVENTION OF VIRAL INFECTION WITH IMMUNE ACTIVATORSAbandonedJun 18, 08Apr 29, 10[A61K, A61P]
2009/0304,630 Treating severe and acute viral infectionsAbandonedAug 02, 07Dec 10, 09[A61K, A61P]
2006/0035,859 Treating severe and acute viral infectionsAbandonedOct 06, 05Feb 16, 06[A61K]
2005/0137,154 Treating server acute respiratory syndromeAbandonedMay 11, 04Jun 23, 05[A61K]
6630455 Methods for inducing mucosal immune responsesExpiredJan 13, 95Oct 07, 03[A61K, A01N, C12N]
5989441 Recovery of functional human leukocytes from recycled filtersExpiredDec 22, 97Nov 23, 99[B01D]
5958718 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunctionExpiredAug 05, 97Sep 28, 99[C12Q, C12N]
5676942 Composition containing human alpha interferon species proteins and method for use thereofExpiredMay 25, 95Oct 14, 97[A61K]
4680175 Interferon administration vehiclesExpiredFeb 07, 84Jul 14, 87[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.